Utility of Presepsin in Distinguishing Between Sepsis and SIRS

Completed

Conditions studied: SIRS, Sepsis

In brief

This is an observational study to evaluate the diagnostic accuracy of presepsin levels to discriminate between sepsis and SIRS upon presentation with critical illness compatible with either sepsis or systemic inflammatory response syndrome (SIRS).

Key facts

Study ID
NCT02052895
Run by
Mochida Pharmaceutical Company, Ltd.
People needed
226
Starts
2014-01-01
Expected to finish
2015-07-01
Last updated by the study team
2018-08-21

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.